Keyphrases
Antibiotics
16%
Aztreonam
16%
Bacteria-resistant
16%
Burkholderia Cepacia
100%
C-reactive Protein
16%
Ceftazidime
16%
Chronic Infection
16%
Chronic Pulmonary Infections
16%
Ciprofloxacin
16%
Cystic Fibrosis
100%
Erythrocyte Sedimentation Rate
16%
Forced Expiratory Volume in 1 Second (FEV1)
50%
Geometric Mean
16%
Imipenem
16%
Intravenous Infusion
16%
Lactams
16%
Leukocyte Count
16%
Meropenem
100%
Minimum Inhibitory Concentration
33%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
100%
Nausea
16%
Piperacillin
16%
Predictive Value
16%
Pseudomonas Aeruginosa (P. aeruginosa)
66%
Pulmonary Function
16%
Rash
16%
Tobramycin
16%
Treatment Value
16%
β-lactam Antibiotics
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
16%
Aztreonam
16%
Beta Lactam
16%
Beta Lactam Antibiotic
100%
Burkholderia cepacia
100%
C Reactive Protein
16%
Ceftazidime
16%
Ciprofloxacin
16%
Cystic Fibrosis
100%
Imipenem
16%
Infection
33%
Infectious Agent
16%
Lung Infection
16%
Meropenem
100%
Nausea
16%
Piperacillin
16%
Pseudomonas aeruginosa
100%
Rash
16%
Side Effect
16%
Tobramycin
16%
Medicine and Dentistry
Allergic Response
33%
Antibiotics
16%
Aztreonam
16%
Beta Lactam
16%
C Reactive Protein
16%
Ceftazidime
16%
Ciprofloxacin
16%
Cystic Fibrosis
100%
Erythrocyte Sedimentation Rate
16%
Exanthem
16%
Hypersensitivity
100%
Infection
33%
Intravenous Drug Administration
16%
Leukocyte
16%
Lung Function
16%
Meropenem
100%
Nausea
16%
Pathogen
16%
Patient with Cystic Fibrosis
16%
Piperacillin
16%
Pseudomonas aeruginosa
100%
Side Effect
16%
Tobramycin
16%
Immunology and Microbiology
Burkholderia cepacia
100%
C-Reactive Protein
20%
Hypersensitive Response
40%
Hypersensitivity
100%
Infectious Agent
20%
Leukocyte Count
20%
Lung Function
20%
Minimum Inhibitory Concentration
40%
Pseudomonas aeruginosa
100%